Myth: glucagon is an effective first-line therapy for esophageal foreign body impaction

Publisher： Cambridge University Press

E-ISSN： 1481-8035|11|2|169-171

ISSN： 1481-8035

Source： Canadian Journal of Emergency Medicine, Vol.11, Iss.2, 2009-03, pp. : 169-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

First-Line Therapy of Mutated Non-Small Cell Lung Cancer: An Update

By  

Oncology Research and Treatment, Vol. 35, Iss. 5, 2012-04 ,pp. : 293-299

Karger

Access to resources Recommend Favorite

Rituximab in Primary Membranous Nephropathy: First-Line Therapy, Why Not?

By  

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 261-269

Karger

Access to resources Recommend Favorite

Docetaxel and Cisplatin as First-Line Treatment for Patients with Metastatic Esophageal Cancer: A Pilot Study

By  

Oncology Research and Treatment, Vol. 28, Iss. 12, 2005-12 ,pp. : 647-650

Karger

Access to resources Recommend Favorite

First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control

By  

Oncology, Vol. 90, Iss. 2, 2016-0 ,pp. : 88-96

Karger

Access to resources Recommend Favorite

Is Second-Line Enuretic Alarm Therapy after Unsuccessful Pharmacotherapy Superior to First-Line Therapy in the Treatment of Monosymptomatic Nocturnal Enuresis?

By  

Urologia Internationalis, Vol. 78, Iss. 3, 2007-04 ,pp. : 260-263

Karger

Access to resources Recommend Favorite